Logo image of SLP

SIMULATIONS PLUS INC (SLP) Stock Fundamental Analysis

USA - NASDAQ:SLP - US8292141053 - Common Stock

15.35 USD
-0.7 (-4.36%)
Last: 10/21/2025, 2:26:13 PM
Fundamental Rating

6

SLP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. SLP has an excellent financial health rating, but there are some minor concerns on its profitability. SLP is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SLP was profitable.
In the past year SLP had a positive cash flow from operations.
In the past 5 years SLP has always been profitable.
SLP had a positive operating cash flow in each of the past 5 years.
SLP Yearly Net Income VS EBIT VS OCF VS FCFSLP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

SLP's Return On Assets of -47.03% is on the low side compared to the rest of the industry. SLP is outperformed by 77.14% of its industry peers.
SLP has a Return On Equity (-51.05%) which is comparable to the rest of the industry.
SLP has a better Return On Invested Capital (3.12%) than 77.14% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SLP is below the industry average of 6.80%.
Industry RankSector Rank
ROA -47.03%
ROE -51.05%
ROIC 3.12%
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
SLP Yearly ROA, ROE, ROICSLP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

In the last couple of years the Profit Margin of SLP has declined.
The Operating Margin of SLP (5.82%) is better than 71.43% of its industry peers.
In the last couple of years the Operating Margin of SLP has declined.
SLP has a Gross Margin of 53.75%. This is comparable to the rest of the industry: SLP outperforms 42.86% of its industry peers.
SLP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.82%
PM (TTM) N/A
GM 53.75%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
SLP Yearly Profit, Operating, Gross MarginsSLP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SLP is destroying value.
Compared to 1 year ago, SLP has more shares outstanding
Compared to 5 years ago, SLP has more shares outstanding
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLP Yearly Shares OutstandingSLP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SLP Yearly Total Debt VS Total AssetsSLP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 19.05 indicates that SLP is not in any danger for bankruptcy at the moment.
SLP has a Altman-Z score of 19.05. This is amongst the best in the industry. SLP outperforms 91.43% of its industry peers.
There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 19.05
ROIC/WACC0.32
WACC9.87%
SLP Yearly LT Debt VS Equity VS FCFSLP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

A Current Ratio of 5.11 indicates that SLP has no problem at all paying its short term obligations.
SLP has a Current ratio of 5.11. This is amongst the best in the industry. SLP outperforms 88.57% of its industry peers.
SLP has a Quick Ratio of 5.11. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
SLP has a better Quick ratio (5.11) than 88.57% of its industry peers.
Industry RankSector Rank
Current Ratio 5.11
Quick Ratio 5.11
SLP Yearly Current Assets VS Current LiabilitesSLP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.30% over the past year.
The Earnings Per Share has been growing slightly by 0.41% on average over the past years.
SLP shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.01%.
The Revenue has been growing by 15.56% on average over the past years. This is quite good.
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%

3.2 Future

SLP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.41% yearly.
The Revenue is expected to grow by 9.89% on average over the next years. This is quite good.
EPS Next Y-567.9%
EPS Next 2Y-7.23%
EPS Next 3Y6.04%
EPS Next 5Y21.41%
Revenue Next Year10.04%
Revenue Next 2Y6.37%
Revenue Next 3Y6.4%
Revenue Next 5Y9.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SLP Yearly Revenue VS EstimatesSLP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
SLP Yearly EPS VS EstimatesSLP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.61, which indicates a rather expensive current valuation of SLP.
Based on the Price/Earnings ratio, SLP is valued cheaper than 91.43% of the companies in the same industry.
SLP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.69.
Based on the Price/Forward Earnings ratio of 36.39, the valuation of SLP can be described as expensive.
Based on the Price/Forward Earnings ratio, SLP is valued a bit cheaper than the industry average as 62.86% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.18. SLP is valued rather expensively when compared to this.
Industry RankSector Rank
PE 23.62
Fwd PE 36.4
SLP Price Earnings VS Forward Price EarningsSLP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SLP is valued a bit cheaper than 74.29% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SLP indicates a somewhat cheap valuation: SLP is cheaper than 74.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 29.29
EV/EBITDA 21.33
SLP Per share dataSLP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)57.15
EPS Next 2Y-7.23%
EPS Next 3Y6.04%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.61%, SLP is not a good candidate for dividend investing.
SLP's Dividend Yield is rather good when compared to the industry average which is at 4.96. SLP pays more dividend than 94.29% of the companies in the same industry.
With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.61%

5.2 History

The dividend of SLP has a limited annual growth rate of 0.01%.
SLP has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.01%
Div Incr Years0
Div Non Decr Years0
SLP Yearly Dividends per shareSLP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

SLP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of SLP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-1.9%
EPS Next 2Y-7.23%
EPS Next 3Y6.04%
SLP Yearly Income VS Free CF VS DividendSLP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

SIMULATIONS PLUS INC

NASDAQ:SLP (10/21/2025, 2:26:13 PM)

15.35

-0.7 (-4.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)07-14 2025-07-14/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners86.07%
Inst Owner Change-0.16%
Ins Owners17.37%
Ins Owner Change-1.85%
Market Cap309.00M
Analysts80
Price Target25.84 (68.34%)
Short Float %9.99%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield 0.61%
Yearly Dividend0.24
Dividend Growth(5Y)0.01%
DP-1.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.9%
Min EPS beat(2)0.69%
Max EPS beat(2)321.12%
EPS beat(4)2
Avg EPS beat(4)55.29%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)3
Avg EPS beat(8)16.77%
EPS beat(12)4
Avg EPS beat(12)5.67%
EPS beat(16)7
Avg EPS beat(16)7.48%
Revenue beat(2)2
Avg Revenue beat(2)0.96%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.3%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)1.3%
Revenue beat(8)5
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)1.72%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-9.09%
EPS NQ rev (3m)-179.21%
EPS NY rev (1m)0%
EPS NY rev (3m)-842.44%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-20.9%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-5.79%
Valuation
Industry RankSector Rank
PE 23.62
Fwd PE 36.4
P/S 3.84
P/FCF 29.29
P/OCF 21.76
P/B 2.5
P/tB 6.16
EV/EBITDA 21.33
EPS(TTM)0.65
EY4.23%
EPS(NY)0.42
Fwd EY2.75%
FCF(TTM)0.52
FCFY3.41%
OCF(TTM)0.71
OCFY4.6%
SpS3.99
BVpS6.15
TBVpS2.49
PEG (NY)N/A
PEG (5Y)57.15
Profitability
Industry RankSector Rank
ROA -47.03%
ROE -51.05%
ROCE 3.77%
ROIC 3.12%
ROICexc 4.04%
ROICexgc 17.48%
OM 5.82%
PM (TTM) N/A
GM 53.75%
FCFM 13.12%
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
ROICexc(3y)12.97%
ROICexc(5y)16.03%
ROICexgc(3y)84.29%
ROICexgc(5y)97.41%
ROCE(3y)5.53%
ROCE(5y)6.08%
ROICexcg growth 3Y-24.94%
ROICexcg growth 5Y-20.15%
ROICexc growth 3Y-47.05%
ROICexc growth 5Y-36.7%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 40.33%
Cap/Sales 4.55%
Interest Coverage 250
Cash Conversion 103.33%
Profit Quality N/A
Current Ratio 5.11
Quick Ratio 5.11
Altman-Z 19.05
F-Score4
WACC9.87%
ROIC/WACC0.32
Cap/Depr(3y)99.44%
Cap/Depr(5y)102.61%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.35%
Profit Quality(3y)126.28%
Profit Quality(5y)123.52%
High Growth Momentum
Growth
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
EPS Next Y-567.9%
EPS Next 2Y-7.23%
EPS Next 3Y6.04%
EPS Next 5Y21.41%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
Revenue Next Year10.04%
Revenue Next 2Y6.37%
Revenue Next 3Y6.4%
Revenue Next 5Y9.89%
EBIT growth 1Y-33.13%
EBIT growth 3Y-18.34%
EBIT growth 5Y-10.46%
EBIT Next Year145.07%
EBIT Next 3Y49.49%
EBIT Next 5Y49.82%
FCF growth 1Y-52.99%
FCF growth 3Y-14.87%
FCF growth 5Y-1.4%
OCF growth 1Y-46.86%
OCF growth 3Y-11.47%
OCF growth 5Y2.73%